FDA ANDA · ANDA216758

SUCRALFATE

Sponsor: NOVITIUM PHARMA

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
ANDA216758
TYPE
ANDA
ORIGINAL APPROVAL
2026-10-14
LATEST ACTION
2026-10-14
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription

Products

SUCRALFATEPrescription
SUCRALFATE 1GM/10ML · SUSPENSION · ORAL

Approval history

2026-10-14UNKNOWN · Original · standardAP